Skip to main content
Log in

Permeability Profiles of M-Alkoxysubstituted Pyrrolidinoethylesters of Phenylcarbamic Acid Across Caco-2 Monolayers and Human Skin

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The purpose of the present research was to study 10 m-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid—potential local anesthetics. The relationships between the structure of the molecule, its physicochemical parameters (log Doct, log k, RM, solubility) were correlated to the permeability data obtained from permeation experiments in Caco-2 monolayers and excised human skin in vitro.

Methods. The extent and mechanism(s) of permeability of the series were studied through a Caco-2 monolayer in the apical-to-basolateral (a-b) and basolateral-to-apical (b-a) directions. The MTT test was performed to determine cellular damage. In vitro transdermal permeability data were obtained from permeation experiments on excised human skin by using side-by-side chambers. Passive diffusion and iontophoretically enhanced permeability were measured.

Results. In Caco-2 monolayers, similar results in the shape of the permeability curves were obtained for the two directions. In the b-a direction, the values of Papp were ∼2-6 times greater than in the a-b direction. A plot of drug permeability vs. the number of carbons in the alkoxychain plateaued first, after which the permeability decreased by the increasing lipophilicity of the drug. If the log Doct of the ester was ≥ 3.4 and the MW > 385 Da, no measurable Caco-2 permeability was found. Cell damage was also higher by the more lipophilic compounds. In excised human skin, the relationship between the passive diffusion of the drugs and the number of carbons in the alkoxychain was parabolic (r 2 = 0.95). Introducing low-level electrical current (iontophoresis), transdermal permeability of the more hydrophilic phenylcarbamic acid esters increased clearly.

Conclusions. Lipophilicity and solubility of a compound have crucial roles in the permeation process. A very high lipophilicity has, however, a negative influence on the permeability, both intestinally and transdermally. Iontophoresis significantly increases the diffusion of small and less lipophilic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. R. A. Conradi, P. S. Burton, and R. T. Borchardt. Physicochemical and biological factors that influence a drug's cellular permeability by passive diffusion. In: V. Pliška, B. Testa and H. van de Waterbeemd (eds.). Lipophilicity in Drug Action and Toxicology. VCH Weinheim, New York, Basel, Cambridge, Tokyo, 1996, pp. 233–252.

    Google Scholar 

  2. B. H. Stewart, O. H. Chan, R. H. Lu, E. L. Reyner, H. L. Schmid, H. W. Hamilton, B. A. Steinbauch, and M. D. Taylor. Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm. Res. 12:693–699 (1995).

    Google Scholar 

  3. K. Palm, K. Luthman, A. L. Ungell, and P. Artursson. Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 85:32–39 (1996).

    Google Scholar 

  4. G. Camenisch, J. Seuz, H. van de Waterbeemd, and G. Folkers. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 6:313–319 (1998).

    Google Scholar 

  5. G. Camenisch, G. Folkers, and H. van de Waterbeemd. Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway. Eur. J. Pharm. Sci. 6:321–329 (1998).

    Google Scholar 

  6. G. L. Flynn. Mechanism of percutaneous absorption from physicochemical evidence. In: R. L. Bronaugh and H. I. Maibach (eds.). Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery. Marcel Dekker Inc., New York and Basel, 1989, pp. 27–51.

    Google Scholar 

  7. R. O. Potts and R. H. Guy. Predicting skin permeability. Pharm. Res. 9:663–669 (1992).

    Google Scholar 

  8. R. O. Potts and R. H. Guy. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 12:1628–1633 (1995).

    Google Scholar 

  9. M. Meylan and P. H. Howard. Atom/fragment contribution method for estimating octanol-water partition coefficient. J. Pharm. Sci. 84:83–91 (1995).

    Google Scholar 

  10. A. Pagliara, M. Reist, S. Geinoz, P. A. Carrupt, and B. Testa. Evaluation and prediction of drug permeation. J. Pharm. Pharmacol. 1:1339–1357 (1999).

    Google Scholar 

  11. P. Artursson, K. Palm, and K. Luthman. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 22:67–84 (1996).

    Google Scholar 

  12. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry.Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, BP, August 2000.

  13. R. H. Guy. Current status and future prospects of transdermal drug delivery. Pharm. Res. 13:1765–1769 (1996).

    Google Scholar 

  14. J. Hirvonen, Y. N. Kalia, and R. H. Guy. Transdermal delivery of peptides by iontophoresis. Nature Biotechnol. 14:1710–1713 (1996).

    Google Scholar 

  15. J. Hirvonen and R. H. Guy. Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm. Res. 14:1258–1263 (1997).

    Google Scholar 

  16. J. Čižmárik, E. Polášek, P. Švec, and E. Racanská. ŠtÚdium lokálnych anestetík CX. Príprava, aktivita a rozdel'ovacie koeficienty pyrolidínoetylesterov 2-, 3-a 4-alkoxysubstituovaných kyselín fenylkarbámových, Čes. Slov. Farm. 42:88–91 (1993).

    Google Scholar 

  17. L. Gyürösiová, E. Sedlárová, and J. Čižmárik. Study of local anaesthetics, part 156: some physicochemical and lipophilic properties of o-, m-, p-alkoxysubstituted pyrrolidino-ethylesters of phenylcarbamic acid. Acta Poloniae Pharmaceutica. In press.

  18. L. Jørgensen, P. Artursson, and E. Bechgaard. Toxicological and absorption enhancing effects of glycofurol 75 and sodium glycocholate in monolayers of human intestinal epithelial (Caco-2) cells. Int. J. Pharm. 95:209–217 (1993).

    Google Scholar 

  19. H. van de Waterbeemd, M. Kansy, B. Wagner, and H. Fisher. Lipophilicity measurement by reversed-phase high performance liquid chromatography (RP-HPLC). In: V. Pliska, B. Testa, and H. van de Waterbeemd (eds.). Lipophilicity in Drug Action and Toxicology. VCH Weinheim, New York, Basel, Cambridge, Tokyo, 1996, pp. 73–88.

    Google Scholar 

  20. H. Kubinyi. QSAR: Hansch Analysis and Approaches. VCH, Weinheim, New York, Basel, Cambridge, Tokyo, 1996.

    Google Scholar 

  21. G. Cimpan, M. Hadaruga, and V. Miclaus. Lipophilicity characterization by reversed-phase liquid chromatography of some furan derivates. J. Chromatogr. A 869:49–55 (2000).

    Google Scholar 

  22. O. Planis?k and S. Sr?i?. Some physicochemical properties of 7-oxoacyl-L-alanyl-D-isoglutamines. Int. J. Pharm. 187:199–207 (1999).

    Google Scholar 

  23. P. Artursson, A. L. Ungell, and J. E. Löfroth. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res. 10:123–1129 (1993).

    Google Scholar 

  24. F. Andriamainty and J. Čižmárik. Study of local anaesthetics. Part 154: study of micellization of the homologos of heptacainum chloride. C?s. Slov. Farm. In press.

  25. J. T. Penniston, L. Beckett, D. L. Bentley, and C. Hansch. Passive permeation of organic compounds through biological tissues: a non-steady state theory. Mol. Pharmacol. 5:333–341 (1969).

    Google Scholar 

  26. O. Díez-Sales, A. C. Watkinson, M. Herráez-Dominguez, C. Javaloyes, and J. Hadgraft. A mechanistic investigation of the in vitro human skin permeation enhancing effect of Azone®. Int. J. Pharm. 129:33–40 (1996).

    Google Scholar 

  27. V. H. Le and B. C. Lippold. Influence of physicochemical properties of homologous esters of nicotinic acid on skin permeability and maximum flux. Int. J. Pharm. 124:285–292 (1995).

    Google Scholar 

  28. K. Kontturi and L. Murtomäki. Mechanistic model for transdermal transport including iontophoresis. J. Control. Release 41:177–185 (1996).

    Google Scholar 

  29. K. C. Sung, J. Y. Fang, and O. Y. P. Hu. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. J. Control. Release 67:1–8 (2000).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jouni Hirvonen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gyürösiová, L., Laitinen, L., Raiman, J. et al. Permeability Profiles of M-Alkoxysubstituted Pyrrolidinoethylesters of Phenylcarbamic Acid Across Caco-2 Monolayers and Human Skin. Pharm Res 19, 162–168 (2002). https://doi.org/10.1023/A:1014208515545

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014208515545

Navigation